A diagnostic test kit for the combined detection of multiple gene methylation markers in blood samples for colorectal cancer screening and detection using methylation analysis technology.
Manufactured by
China
Singlera Genomics is a China-based manufacturer of in vitro diagnostic (IVD) reagents and instruments specializing in DNA methylation-based cancer early detection and liquid biopsy testing. The company produces diagnostic products for multiple cancer types including colorectal, liver, gastric, esophageal, and pancreatic cancers, with manufacturing facilities in Yangzhou and Wuxi. Singlera holds ISO 13485 certification, CAP accreditation, US CLIA laboratory certification, and is designated as a National High-tech Enterprise in China.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Clinomics Europe Kft.
Hungary · 1 relevant product
BioChain (Beijing) Science & Technology. Inc.
China · 8 relevant products
Suzhou Linaxin Biotechnology Co., Ltd.
China · 4 relevant products
Yaneng BIOscience (Shenzhen) Co.,Ltd.
China · 6 relevant products
S&T BioMed CO., LTD.
Taiwan · 3 relevant products
TRUPCR Europe Ltd
United Kingdom · 6 relevant products
SHMY HEALTHDIGIT BIOCHIPS CO.,LTD
China · 1 relevant product
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept
India · 1 relevant product
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 4 relevant products
Genetic Tools, LLC
United States · 1 relevant product
35 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →1 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 95 closest product alternatives
Clinomics Europe Kft. · Hungary
Multi-gene methylation detection test for colorectal cancer screening and risk assessment. Uses advanced liquid biopsy technology to identify epigenetic biomarkers associated with colorectal malignancy. Enables non-invasive early detection and personalized patient stratification for clinical decision-making.
BioChain (Beijing) Science & Technology. Inc. · China
A blood-based gene methylation detection kit for hepatocellular carcinoma with industry-leading performance metrics. This approved product is part of BioChain's comprehensive coverage of major digestive system cancers.
BioChain (Beijing) Science & Technology. Inc. · China
Gene methylation-based diagnostic test for early detection of hepatocellular carcinoma with industry-leading performance metrics. This blood-based test enables non-invasive screening for liver cancer risk stratification. The product is approved by NMPA and integrated into multiple hospital and insurance systems.
Suzhou Linaxin Biotechnology Co., Ltd. · China
A home-based colorectal cancer early screening product that detects multi-gene mutations combined with DNA methylation in fecal exfoliated cells from the intestinal tract. It features 6 target genes and over 30 mutation sites, enabling non-invasive and painless screening that can identify colorectal cancer risk 5-7 years in advance. The test can be performed at home without hospital visits.
BioChain (Beijing) Science & Technology. Inc. · China
The world's first approved gene methylation early detection product for esophageal cancer, representing a breakthrough in early cancer diagnosis. This product has received NMPA certification and is part of BioChain's comprehensive digestive system cancer screening portfolio.
BioChain (Beijing) Science & Technology. Inc. · China
A blood-based gene methylation early detection product for colorectal cancer that was the first in China to receive NMPA approval and is marketed under the brand name Siboding®. The product has received authorizations from the FDA, NMPA, and EU CE, representing the world's earliest simultaneous approval from all three major regulatory bodies.
BioChain (Beijing) Science & Technology. Inc. · China
A comprehensive blood-based screening service designed to detect multiple cancer types simultaneously through gene methylation analysis. This service utilizes advanced NGS technology and is available as a clinical testing service.
Yaneng BIOscience (Shenzhen) Co.,Ltd. · China
Molecular diagnostic kit for detecting colorectal cancer-associated genetic alterations. Provides genetic risk assessment for colorectal malignancy.
Suzhou Linaxin Biotechnology Co., Ltd. · China
A combined fecal occult blood and fecal DNA genetic testing kit for cancer early screening. This diagnostic product detects multiple biomarkers including occult blood and genetic markers in stool samples to assess colorectal cancer risk.
S&T BioMed CO., LTD. · Taiwan
A blood exosome detection kit specifically designed for colorectal cancer screening. The kit employs advanced protein biomarker detection and magneto-electrochemical technology for accurate cancer diagnosis.
TRUPCR Europe Ltd · United Kingdom
A diagnostic test kit designed to detect mutations associated with colorectal cancer. This panel enables identification of genetic alterations relevant to colorectal cancer diagnosis and management.
SHMY HEALTHDIGIT BIOCHIPS CO.,LTD · China
Multi-tumor marker detection kit utilizing protein chip technology with chemiluminescence for simultaneous identification of multiple cancer biomarkers in blood and serum samples. Designed for clinical diagnosis and monitoring of various malignancies, this in vitro diagnostic test enables rapid quantitative analysis to support oncology patient management and treatment decisions.
83 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products